These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 21536612)

  • 1. Reproducibility of acute mountain sickness in children and adults: a prospective study.
    Rexhaj E; Garcin S; Rimoldi SF; Duplain H; Stuber T; Allemann Y; Sartori C; Scherrer U
    Pediatrics; 2011 Jun; 127(6):e1445-8. PubMed ID: 21536612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute mountain sickness in children and their parents after rapid ascent to 3500 m (Putre, Chile).
    Moraga FA; Pedreros CP; Rodríguez CE
    Wilderness Environ Med; 2008; 19(4):287-92. PubMed ID: 19099320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute mountain sickness in travelers who consulted a pre-travel clinic.
    Croughs M; Van Gompel A; Van den Ende J
    J Travel Med; 2011; 18(5):337-43. PubMed ID: 21896098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of acute mountain sickness in adolescents.
    Dallimore J; Rowbotham EC
    Wilderness Environ Med; 2009; 20(3):221-4. PubMed ID: 19737028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute mountain sickness in Jade Mountain climbers of Taiwan.
    Kao WF; Kuo CC; Hsu TF; Chang H; Sung YY; Yen DH; Wu JK; Lee CH
    Aviat Space Environ Med; 2002 Apr; 73(4):359-62. PubMed ID: 11952056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ginkgo biloba does--and does not--prevent acute mountain sickness.
    Leadbetter G; Keyes LE; Maakestad KM; Olson S; Tissot van Patot MC; Hackett PH
    Wilderness Environ Med; 2009; 20(1):66-71. PubMed ID: 19364166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and time course of acute mountain sickness in older children and adolescents after rapid ascent to 3450 meters.
    Bloch J; Duplain H; Rimoldi SF; Stuber T; Kriemler S; Allemann Y; Sartori C; Scherrer U
    Pediatrics; 2009 Jan; 123(1):1-5. PubMed ID: 19117853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual analog scale (VAS) for assessment of acute mountain sickness (AMS) on Aconcagua.
    Van Roo JD; Lazio MP; Pesce C; Malik S; Courtney DM
    Wilderness Environ Med; 2011 Mar; 22(1):7-14. PubMed ID: 21377113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of acute mountain sickness by different score protocols in the Swiss Alps.
    Maggiorini M; Müller A; Hofstetter D; Bärtsch P; Oelz O
    Aviat Space Environ Med; 1998 Dec; 69(12):1186-92. PubMed ID: 9856545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute mountain sickness in children at 4380 meters in the Himalayas.
    Pradhan S; Yadav S; Neupane P; Subedi P
    Wilderness Environ Med; 2009; 20(4):359-63. PubMed ID: 20030445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermittent altitude exposures reduce acute mountain sickness at 4300 m.
    Beidleman BA; Muza SR; Fulco CS; Cymerman A; Ditzler D; Stulz D; Staab JE; Skrinar GS; Lewis SF; Sawka MN
    Clin Sci (Lond); 2004 Mar; 106(3):321-8. PubMed ID: 14561214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spironolactone does not prevent acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial by SPACE Trial Group (spironolactone and acetazolamide trial in the prevention of acute mountain sickness group).
    Basnyat B; Holck PS; Pun M; Halverson S; Szawarski P; Gertsch J; Steif M; Powell S; Khanal S; Joshi A; Shankar R; Karambay J; Alexander HD; Stone A; Morrissey C; Thompson BH; Farrar J;
    Wilderness Environ Med; 2011 Mar; 22(1):15-22. PubMed ID: 21377114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sumatriptan for prevention of acute mountain sickness: randomized clinical trial.
    Jafarian S; Gorouhi F; Salimi S; Lotfi J
    Ann Neurol; 2007 Sep; 62(3):273-7. PubMed ID: 17557349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are we doing our best to educate travelers about the risks of acute mountain sickness? An on-site prospective study in the Himalayas.
    Paz A; Steinfeld I; Potasman I
    J Travel Med; 2007; 14(3):168-72. PubMed ID: 17437472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial.
    Chow T; Browne V; Heileson HL; Wallace D; Anholm J; Green SM
    Arch Intern Med; 2005 Feb; 165(3):296-301. PubMed ID: 15710792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Everest or bust: a cross sectional, epidemiological study of acute mountain sickness at 4243 meters in the Himalayas.
    Basnyat B; Lemaster J; Litch JA
    Aviat Space Environ Med; 1999 Sep; 70(9):867-73. PubMed ID: 10503751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute mountain sickness and ascent rates in trekkers above 2500 m in the Nepali Himalaya.
    Vardy J; Vardy J; Judge K
    Aviat Space Environ Med; 2006 Jul; 77(7):742-4. PubMed ID: 16856361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of diagnostic criteria and incidence of acute mountain sickness in preverbal children.
    Yaron M; Niermeyer S; Lindgren KN; Honigman B
    Wilderness Environ Med; 2002; 13(1):21-6. PubMed ID: 11929057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of altitude pre-acclimatization on acute mountain sickness during reexposure.
    Lyons TP; Muza SR; Rock PB; Cymerman A
    Aviat Space Environ Med; 1995 Oct; 66(10):957-62. PubMed ID: 8526832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Incidence of acute mountain sickness at intermediate altitude in the Austrian alps].
    Röggla G; Röggla M; Hirschl MM; Wagner A; Laggner AN
    Wien Klin Wochenschr Suppl; 1992; 194():7-10. PubMed ID: 1288024
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.